Andrea Ferrigno
Overview
Explore the profile of Andrea Ferrigno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
759
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Di Pasqua L, Abdallah M, Feletti F, Vairetti M, Ferrigno A
Pharmaceuticals (Basel)
. 2024 Apr;
17(4).
PMID: 38675444
Venetoclax is a Bcl-2 homology domain 3 (BH3) mimetic currently approved for the treatment of chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) that has proven to be highly...
2.
Vairetti M, Colucci G, Ferrigno A
Int J Mol Sci
. 2024 Apr;
25(7).
PMID: 38612820
The aim of this Special Issue is to provide an update on the diagnosis and treatment of nonalcoholic fatty liver disease (NAFLD), which is the most prevalent liver disease worldwide;...
3.
Palladini G, Di Pasqua L, Croce A, Ferrigno A, Vairetti M
Int J Mol Sci
. 2023 Dec;
24(24).
PMID: 38139236
The reversion-inducing cysteine-rich protein with Kazal motifs (RECK), a membrane-anchored glycoprotein, negatively regulates various membrane proteins involved in the tissue governing extracellular matrix (ECM) remodeling such as metalloproteases (MMPs) and...
4.
Di Pasqua L, Cagna M, Palladini G, Croce A, Cadamuro M, Fabris L, et al.
Liver Int
. 2023 Oct;
44(1):214-227.
PMID: 37904642
Background And Aims: We have previously shown in a model of hepatic ischaemia/reperfusion injury that the farnesoid X receptor (FXR) agonist obeticholic acid (OCA) restores reversion-inducing-cysteine-rich protein with Kazal motifs...
5.
Ferrigno A, Campagnoli L, Barbieri A, Marchesi N, Pascale A, Croce A, et al.
Int J Mol Sci
. 2023 Jun;
24(12).
PMID: 37372956
The endogenous antioxidant defense plays a big part in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), a common metabolic disorder that can lead to serious complications such as cirrhosis...
6.
Croce A, Ferrigno A, Palladini G, Mannucci B, Vairetti M, Di Pasqua L
Molecules
. 2023 May;
28(9).
PMID: 37175228
The autofluorescence of specific fatty acids, retinoids, and bilirubin in crude serum can reflect changes in liver functional engagement in maintaining systemic metabolic homeostasis. The role of these fluorophores as...
7.
Ferrigno A, Cagna M, Bosco O, Trucchi M, Berardo C, Nicoletti F, et al.
Int J Mol Sci
. 2023 Apr;
24(7).
PMID: 37047048
The blockade of metabotropic glutamate receptor type 5 (mGluR5) was previously found to reduce fat accumulation in HEPG2 cells. Here, we evaluated the effects of mGluR5 blockade in a mouse...
8.
Turato C, Vairetti M, Cagna M, Biasiolo A, Ferrigno A, Quarta S, et al.
Eur J Histochem
. 2022 Oct;
66(4).
PMID: 36305270
We have investigated the change in SerpinB3 during hepatic ischemia and the potential role of its antiprotease activity in cell protection by the administration of wild-type SerpinB3 (SerpinB3-WT) or active...
9.
Croce A, Palladini G, Ferrigno A, Vairetti M
Methods Mol Biol
. 2022 Sep;
2566:29-35.
PMID: 36152239
Autofluorescence rising from biological substrates under proper excitation light depends on the presence of specific endogenous fluorophores and can provide information on the morpho-functional properties in which they are strictly...
10.
Campagnoli L, Marchesi N, Vairetti M, Pascale A, Ferrigno A, Barbieri A
Cells
. 2022 Sep;
11(18).
PMID: 36139402
Human aging, a natural process characterized by structural and physiological changes, leads to alterations of homeostatic mechanisms, decline of biological functions, and subsequently, the organism becomes vulnerable to external stress...